Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$2.85
+0.00%
Mkt Cap $2.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$7.25
Range $4.50 – $10.00
Implied Upside
+154.4%
Consensus $7.25 vs current $2.85
AMEX·Healthcare·Biotechnology
$2.85
+0.00%
Mkt Cap $2.20M
No recent rating data.
Price Target (2 analysts)
$7.25
Range $4.50 – $10.00
+154.4%
Consensus $7.25 vs current $2.85